Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
Monetary Elite A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
SanDisk Is Down 15% This Week. BofA Just Raised Its Target to $2,500.
The AI memory shortage that drove a 700% gain is still intact. The pullback is the story.
SpaceX Is Now Public. The Real Question Starts Now.
SPCX went public at $135 and hit $225 in four days. Now it's back near $157. So what is this…
Broadcom Is Down 25% From Its High. The AI Numbers Say Something Different.
Custom chip revenue just grew 143% year over year. The selloff may be the opportunity.
Meta Is Trading at $621 and the July 29 Number Is the Only Thing That Matters
A 33% revenue beat, a $125B–$145B capex bill, and a stock still 22% off its all-time high.
Broadcom Is Down 25% From Its High. The Business Has Never Been Better.
Record AI revenue, a custom OpenAI chip, and a $1.8 trillion company trading at a discount.
Snowflake Just Had Its Best Quarter Ever. The Stock Hasn’t Caught Up.
Revenue grew 33% in Q1. A $6 billion AWS deal sealed the AI pivot.
The Iran Deal Is Signed. The Market Has Not Finished Repricing It.
What a 60-day ceasefire actually means for energy, equities, and the second-order trades most investors are missing.
Europe Just Declared Tech Independence. The $420 Billion Bill Goes to U.S. Companies.
The EU's Tech Sovereignty Package is the biggest regulatory risk nobody is modeling.
NKE Reports June 30. The Stock Is Down 40% and Expectations Are Already in the Gutter.
Options traders are pricing an 8.5% move. The real question is what happens to gross margin.